Product information
From Health Canada
Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.
Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.
Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.
- Natural Product Number (NPN):
- 80096884
- Market status:
- Marketed
- Licence Status:
- Active
- Brand name(s):
-
Lung-FX
;
LUNG-FX FORMULA - Licence holder:
- Healthology International Inc.
- Dosage Form:
- Capsule
- Recommended route of administration:
-
Oral
Sub population (Sub Pop.) | Quantity (Qty) | Frequency (Freq.) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sub Pop. | Age | Min. | Max. | UoM Footnote1 Age | Qty | Min. | Max. | UoM Qty | Freq. | Min. | Max. | UoM Freq. |
Adults | 19 | year(s) | 3.0 | capsule | 1 | daily | ||||||
- Recommended use or purpose:
- Source of/Provides antioxidants. Fenugreek and Hyssop are traditionally used in Herbal Medicine as an expectorant to help relieve excess mucous of the upper respiratory passages (anti-catarrhal).
- Risk Information:
- Cautions and Warnings
- Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you have kidney stones Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you have diabetes Consult a health care practitioner prior to use if you have had recent surgery or have upcoming surgery. Keep out of reach of children. Consult a health care practitioner/health care provider/health care professional/doctor/ physician if symptoms persist or worsen. Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you are breastfeeding.
- Contra-Indications
- Do not use this product if you are taking antibiotics or nitroglycerin. Do not use this product if you are pregnant.
- Known Adverse Reactions
- Stop use if hypersensitivity/allergy occurs.
Medicinal ingredients | Quantity (Qty) | Extract | Potency |
---|---|---|---|
Ganoderma lucidum |
50.0 mg
|
20
:
1
DHE: 1 g Dry |
|
Hyssopus officinalis |
100.0 mg
|
10
:
1
DHE: 1 g Dry |
|
N-Acetyl-L-cysteine |
200.0 mg
|
||
Trigonella foenum-graecum |
150.0 mg
|
10
:
1
DHE: 1.5 g Dry |
|
Verbascum thapsus |
100.0 mg
|
20
:
1
DHE: 2 g Dry |
|
Zingiber officinale |
100.0 mg
|
4
:
1
DHE: 400 mg Dry |
- List of non-medicinal ingredients:
-
- Hypromellose
- Maltodextrin
- Oryza sativa (Rice) hull powder
- Date of licensing:
- 2020-01-29
- Revised date of licence:
- 2021-08-30
Application information
Related information
Contact us
For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).